UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Plasma neurofilament light chain as a potential biomarker in Charcot‐Marie‐Tooth disease

Millere, E; Rots, D; Simrén, J; Ashton, NJ; Kupats, E; Micule, I; Priedite, V; ... Kenina, V; + view all (2021) Plasma neurofilament light chain as a potential biomarker in Charcot‐Marie‐Tooth disease. European Journal of Neurology , 28 (3) pp. 974-981. 10.1111/ene.14689. Green open access

[thumbnail of ene.14689.pdf]
Preview
Text
ene.14689.pdf - Accepted Version

Download (8MB) | Preview

Abstract

BACKGROUND: Charcot-Marie-Tooth disease (CMT) is a chronic, slowly progressing disorder. The lack of specific disease progression biomarkers limits the execution of clinical trials. However, neurofilament light chain (NfL) has been suggested as a potential biomarker for peripheral nervous system disorders. METHODS: Ninety-six CMT patients and 60 healthy controls were enrolled in the study. Disease severity assessment included clinical evaluation with CMT Neuropathy Score version 2 (CMTNSv2). Blood plasma NfL concentrations were measured using the single molecule array (Simoa) NfL assay. RESULTS: The NfL concentration was significantly higher in the CMT patient group than in the controls (p<0.001). Of the CMT patients, ones with type CMTX1 had a higher NfL level than those in the two other analysed subgroups (CMT1A and other CMT types) (p=0.0498). The NfL concentration had a significant but weak correlation with the CMTNSv2 (rs =0.25, p=0.012). In one CMT patient with an extremely elevated NfL level, overlap with chronic inflammatory demyelinating polyneuropathy was suspected. ROC analysis showed that an NfL concentration of 8.9 pg/mL could be used to discriminate CMT patients from controls, with an area under the curve of 0.881. CONCLUSIONS: Our study confirmed that the plasma NfL concentration is significantly higher in CMT patients than in controls. Plasma NfL concentration was found to significantly, albeit weakly, reflect the clinical severity of CMT. In the future, NfL may be used, either individually or collaboratively, as a biomarker in the clinical context of suspected CMT; however, several issues need to be addressed first.

Type: Article
Title: Plasma neurofilament light chain as a potential biomarker in Charcot‐Marie‐Tooth disease
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1111/ene.14689
Publisher version: https://doi.org/10.1111/ene.14689
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: Polyneuropathy, genetic and inherited disorders
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases
URI: https://discovery.ucl.ac.uk/id/eprint/10118247
Downloads since deposit
Loading...
231Downloads
Download activity - last month
Loading...
Download activity - last 12 months
Loading...
Downloads by country - last 12 months
Loading...

Archive Staff Only

View Item View Item